Structure-Activity Studies on the Spiroketal Moiety of a Simplified Analogue of Debromoaplysiatoxin with Antiproliferative Activity

被引:50
作者
Kikumori, Masayuki [1 ]
Yanagita, Ryo C. [1 ,2 ]
Tokuda, Harukuni [3 ]
Suzuki, Nobutaka [3 ]
Nagai, Hiroshi [4 ]
Suenaga, Kiyotake [5 ]
Irie, Kazuhiro [1 ]
机构
[1] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan
[2] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Kagawa 7610795, Japan
[3] Kanazawa Univ, Dept Complementary & Alternat Med, Clin R&D, Grad Sch Med Sci, Kanazawa, Ishikawa 9208640, Japan
[4] Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Tokyo 1088477, Japan
[5] Keio Univ, Fac Sci & Technol, Yokohama, Kanagawa 2238522, Japan
关键词
PROTEIN-KINASE-C; PHORBOL ESTER BINDING; CATALYTIC ASYMMETRIC ALLYLATION; TUMOR-PROMOTING APLYSIATOXIN; EPSTEIN-BARR VIRUS; PHASE-II TRIAL; BRYOSTATIN; SEQUENTIAL PACLITAXEL; THERAPEUTIC TARGET; TRANSGENIC MICE;
D O I
10.1021/jm300566h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Aplog-1, a simplified analogue of tumor-promoting debromoaplysiatoxin, is antiproliferative but not tumor-promoting. Our recent study has suggested that local hydrophobicity around the spiroketal moiety is a crucial determinant for antiproliferative activity. To further clarify the structural features relevant to the activity, we synthesized two methyl derivatives of aplog-1, where a methyl group was installed at position 4 or 10 of the spiroketal moiety. 10-Methyl-aplog-1 (5) bound to the C1B domains of novel PKCs (delta, eta and theta) with subnanomolar K-i values, approximately 10-20 times stronger than aplog-1, and markedly inhibited the growth of many human cancer cell lines, while 4-methyl-aplog-1 (4) had levels of activity similar to those of aplog-1. Interestingly, 5 showed little tumor-promoting activity unlike the tumor promoter debromoaplysiatoxin. These results suggest that 5 is a potent PKC ligand without tumor-promoting activity and could be a therapeutic lead for the treatment of cancer, like bryostatins.
引用
收藏
页码:5614 / 5626
页数:13
相关论文
共 76 条
[1]   A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma [J].
Ajani, JA ;
Jiang, YX ;
Faust, J ;
Chang, BCB ;
Ho, L ;
Yao, JC ;
Rousey, S ;
Dakhil, S ;
Cherny, RC ;
Craig, C ;
Bleyer, A .
INVESTIGATIONAL NEW DRUGS, 2006, 24 (04) :353-357
[2]  
[Anonymous], 1989, OECD GUIDELINES TE 1
[3]   Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant [J].
Barr, Paul M. ;
Lazarus, Hillard M. ;
Cooper, Brenda W. ;
Schluchter, Mark D. ;
Panneerselvam, Ashok ;
Jacobberger, James W. ;
Hsu, Jack W. ;
Janakiraman, Nalini ;
Simic, Aleksandra ;
Dowlati, Afshin ;
Remick, Scot C. .
AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (08) :484-487
[4]  
Berenblum I, 1941, CANCER RES, V1, P807
[5]   Protein kinase C translocation by modified phorbol esters with functionalized lipophilic regions [J].
Bertolini, TM ;
Giorgione, J ;
Harvey, DF ;
Newton, AC .
JOURNAL OF ORGANIC CHEMISTRY, 2003, 68 (13) :5028-5036
[7]  
CASTAGNA M, 1982, J BIOL CHEM, V257, P7847
[8]   PKCε increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice [J].
Choi, Doo-Sup ;
Wang, Dan ;
Yu, Gui-Qui ;
Zhu, Guofen ;
Kharazia, Viktor N. ;
Paredes, J. Peter ;
Chang, Wesley S. ;
Deitchman, Jason K. ;
Mucke, Lennart ;
Messing, Robert O. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (21) :8215-8220
[9]   IODINE MONOBROMIDE (IBR) AT LOW-TEMPERATURE - ENHANCED DIASTEREOSELECTIVITY IN ELECTROPHILIC CYCLIZATIONS OF HOMOALLYLIC CARBONATES [J].
DUAN, JJW ;
SMITH, AB .
JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (14) :3703-3711
[10]   Total synthesis of bryostatin 2 [J].
Evans, DA ;
Carter, PH ;
Carreira, EM ;
Charette, AB ;
Prunet, JA ;
Lautens, M .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (33) :7540-7552